Table 7  Outcomes of patients with COVID-19-associated ARDS according to Aspergillus status.
Outcomes  All Patients (n = 45)  No Aspergillosis (n = 30)  Aspergillus Colonization (n = 8)  Putative/Probable Invasive Aspergillosis (n = 7)  p Value
Duration of mechanical ventilation  17 (9–24)  17 (7–24)  18 (10–21)  18 (12–30)  0.66
Ventilator free days at day 28  11 (4–19)  11 (4–21)  10 (7–18)  10 (0–16)  0.64
Prone positioning ventilation  20 (44)  12 (46)  3 (37.5)  5 (71.4)  0.29
SOFA score on day 7  7 (5–11)  6 (5–10)  8 (7–10)  11 (10–12)  0.01
SOFA score on day 14  7 (2–10)  7 (2–9)  3 (1–7)  9 (2–12)  0.2
ICU length of stay  20 (12–27)  12 (11–23)  23 (16–51)  27 (20–36)  0.02
Death in ICU  6 (13.3)  4 (13.3)  0  2 * (28.6)  0.27
Data are presented as median (IQR: interquartiles), n (%). P values comparing Aspergillus colonization, invasive aspergillosis and no aspergillosis groups are tested by Kruskal Wallis (continuous variables) or Chi-square test (categorical variables). Abbreviations: ICU: Intensive Care Unit, SOFA: Sequential Organ Failure Assessment, * 1 putative and 1 probable.